Or Eisenberg insider trades: NeuroSense Therapeutics (NRSN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Or reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | NRSN | ↑ Buy | 250,000 | $0.80 | $200K | Direct | Jun 17, 2026 (1d) |
| Mar 9, 2021 | WIZP | ↑ Buy | 833,333 | $0.12 | $100K | Direct | Mar 11, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NRSN insiders
Open-market trades in the last 12 months
About Or Eisenberg's insider trades
Or Eisenberg is Chief Financial Officer at NeuroSense Therapeutics (NRSN). Since Mar 9, 2021, Or has reported 2 open-market purchases worth $300K and no sales on SEC Form 4. In the last 12 months: 1 buy ($200K).
Their filings also include grants and awards (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRSN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.